Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:59 AM
Ignite Modification Date:
2025-12-25 @ 1:59 AM
NCT ID:
NCT01676194
Eligibility Criteria:
Inclusion Criteria:
* Adult patients \>18 years
* With well compensated cirrhosis and hepatocellular carcinoma meeting UCSF criteria
* Without general contraindication to LT
* Written informed consent.
Exclusion Criteria:
* Patients that already had TACE
* Or other local treatment for HCC
* Or neoadjuvant systemic chemotherapy
* Or planned living donor
* Or non arterialized lesion(s)
* Or Contraindication to DC-BeadsR
* Or allergy to contrast agents
* Or contraindication to Doxorubicin.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01676194
Study Brief:
Protocol Section:
NCT01676194